U.K. stocks rebound from 1-month low as AstraZeneca rises after trial results

U.K. stock rebounded from a one-month low on Friday, shaking off a continued rally in the pound as drugmakers advanced after industry heavyweight AstraZeneca released positive trial results.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.